Literature DB >> 17131344

Disease-associated casein kinase I delta mutation may promote adenomatous polyps formation via a Wnt/beta-catenin independent mechanism.

I-Chun Tsai1, Margaret Woolf, Deborah W Neklason, William W Branford, H Joseph Yost, Randall W Burt, David M Virshup.   

Abstract

The Wnt signaling pathway is critical for embryonic development and is dysregulated in multiple cancers. Two closely related isoforms of casein kinase I (CKIdelta and epsilon) are positive regulators of this pathway. We speculated that mutations in the autoinhibitory domain of CKIdelta/epsilon might upregulate CKIdelta/epsilon activity and hence Wnt signaling and increase the risk of adenomatous polyps and colon cancer. Exons encoding the CKIepsilon and CKIdelta regulatory domains were sequenced from DNA obtained from individuals with adenomatous polyps and a family history of colon cancer unaffected by familial adenomatous polyposis or hereditary nonpolyposis colorectal cancer (HNPCC). A CKIdelta missense mutation, changing a highly conserved residue, Arg324, to His (R324H), was found in an individual with large and multiple polyps diagnosed at a relatively young age. Two findings indicate that this mutation is biologically active. First, ectopic ventral expression of CKIdelta(R324H) in Xenopus embryos results in secondary axis formation with an additional distinctive phenotype (altered morphological movements) similar to that seen with unregulated CKIepsilon. Second, CKIdelta(R324H) is more potent than wildtype CKIdelta in transformation of RKO colon cancer cells. Although the R324H mutation does not significantly change CKIdelta kinase activity in an in vitro kinase assay or Wnt/beta-catenin signal transduction as assessed by a beta-catenin reporter assay, it alters morphogenetic movements via a beta-catenin-independent mechanism in early Xenopus development. This novel human CKIdelta mutation may alter the physiological role and enhance the transforming ability of CKIdelta through a Wnt/beta-catenin independent mechanism and thereby influence colonic adenoma development. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17131344     DOI: 10.1002/ijc.22368

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

Review 1.  Circadian gene variants in cancer.

Authors:  Nicole M Kettner; Chinenye A Katchy; Loning Fu
Journal:  Ann Med       Date:  2014-06-05       Impact factor: 4.709

2.  Potential of casein kinase I in digestive cancer screening.

Authors:  Cristina Modak; Jianyuan Chai
Journal:  World J Gastrointest Oncol       Date:  2009-10-15

3.  Targeting Casein Kinase 1 Delta Sensitizes Pancreatic and Bladder Cancer Cells to Gemcitabine Treatment by Upregulating Deoxycytidine Kinase.

Authors:  Francesca Vena; Simon Bayle; Ainhoa Nieto; Victor Quereda; Massimiliano Aceti; Sylvia M Frydman; Samer S Sansil; Wayne Grant; Andrii Monastyrskyi; Patricia McDonald; William R Roush; Mingxiang Teng; Derek Duckett
Journal:  Mol Cancer Ther       Date:  2020-05-19       Impact factor: 6.261

Review 4.  Structure, regulation, and (patho-)physiological functions of the stress-induced protein kinase CK1 delta (CSNK1D).

Authors:  Pengfei Xu; Chiara Ianes; Fabian Gärtner; Congxing Liu; Timo Burster; Vasiliy Bakulev; Najma Rachidi; Uwe Knippschild; Joachim Bischof
Journal:  Gene       Date:  2019-07-31       Impact factor: 3.688

5.  Decreased CK1δ expression predicts prolonged survival in colorectal cancer patients.

Authors:  Julia Richter; Steven Rudeck; Anna-Laura Kretz; Klaus Kramer; Steffen Just; Doris Henne-Bruns; Andreas Hillenbrand; Frank Leithäuser; Johannes Lemke; Uwe Knippschild
Journal:  Tumour Biol       Date:  2016-01-07

6.  Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function.

Authors:  Sharon Lim; Tzuen Yih Saw; Min Zhang; Matthew R Janes; Kassoum Nacro; Jeffrey Hill; An Qi Lim; Chia-Tien Chang; David A Fruman; David A Rizzieri; Soo Yong Tan; Hung Fan; Charles T H Chuah; S Tiong Ong
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-04       Impact factor: 11.205

7.  Therapeutic targeting of casein kinase 1δ in breast cancer.

Authors:  Laura H Rosenberg; Marie Lafitte; Victor Quereda; Wayne Grant; Weimin Chen; Mathieu Bibian; Yoshihiko Noguchi; Mohammad Fallahi; Chunying Yang; Jenny C Chang; William R Roush; John L Cleveland; Derek R Duckett
Journal:  Sci Transl Med       Date:  2015-12-16       Impact factor: 17.956

8.  Hrr25/CK1δ-directed release of Ltv1 from pre-40S ribosomes is necessary for ribosome assembly and cell growth.

Authors:  Homa Ghalei; Franz X Schaub; Joanne R Doherty; Yoshihiko Noguchi; William R Roush; John L Cleveland; M Elizabeth Stroupe; Katrin Karbstein
Journal:  J Cell Biol       Date:  2015-03-16       Impact factor: 10.539

Review 9.  The CK1 Family: Contribution to Cellular Stress Response and Its Role in Carcinogenesis.

Authors:  Uwe Knippschild; Marc Krüger; Julia Richter; Pengfei Xu; Balbina García-Reyes; Christian Peifer; Jakob Halekotte; Vasiliy Bakulev; Joachim Bischof
Journal:  Front Oncol       Date:  2014-05-19       Impact factor: 6.244

10.  CK1delta modulates the transcriptional activity of ERalpha via AIB1 in an estrogen-dependent manner and regulates ERalpha-AIB1 interactions.

Authors:  Georgios Giamas; Leandro Castellano; Qin Feng; Uwe Knippschild; Jimmy Jacob; Ross S Thomas; R Charles Coombes; Carolyn L Smith; Long R Jiao; Justin Stebbing
Journal:  Nucleic Acids Res       Date:  2009-04-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.